American Diabetes Association.Diagnosis and classification of diabetes. Diabetes Care.2006;29:S43-S48.
2.
Guilleminault C., Bassiri A.Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome and upper airway resistance syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine2nd ed. Philadelphia, Pa: ElsevierSaunders;2005:1043-1052.
3.
Bliwise DL, Feldman DE, Bliwise NG, et al. Risk factors for sleep disordered breathing in heterogeneous geriatric populations. J Am Geriatr Soc.1987 ;35:132-141.
4.
Mokdad AH, Bowman BA, Ford ES, Vinicor F., Marks JS, Koplan JPThe continuing epidemics of obesity and diabetes in the United States. JAMA.2001;286:1195-1200.
5.
Engleman HM, Martin SE, Deary IJ, Douglas NJEffect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997;52:114-119.
6.
Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJRandomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med.1999;159:461-467.
7.
Faccenda J., Mackay T., Boon N., Douglas N.Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med.2001;163:344-348.
8.
Jenkinson C. , Davies R., Mullins R., Stradling J.Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999;353:2100-2105.
9.
Weaver T., Honbo B., Maislin G., et al. Improvement in affect after 3 mo. CPAP: multi-center study. Am J Respir Crit Care Med.1999;159:A770.
10.
Schwab R, Kuna S, Remmers JE.Anatomy and physiology of upper airway obstruction. In: Kryger M, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine4th ed. Philadelphia, Pa: ElsevierSaunders;2005:983-1000.
11.
Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA.2000;283:1829-1836.
12.
George CF, Smiley A.Sleep apnea & automobile crashes. Sleep.1999;22:790-795.
13.
Shahar E., Whitney CW, Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med.2001; 163:19-25.
14.
Young T., Peppard P.Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep. 2000;23: S 122-S126.
15.
Peppard PE, Young T., Palta M., Skatrud J.Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med.2000;342:1378-1384.
16.
Shepard JW Jr.Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med.1992;13:437-458.
17.
American Academy of Sleep Medicine Task Force.Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep.1999;22:667-689.
18.
Engleman HM , Cheshire KE, Deary IJ, Douglas NJDaytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax. 1993;48:911-914.
19.
Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am J Respir Crit Care Med.1993;147: 1162-1168.
20.
Ip MS, Lam B., Ng MM, Lam WK, Tsang KW, Lam KSObstructive sleep apnea is independently associated with insulin resistance . Am J Respir Crit Care Med.2002;165:670-676.
21.
Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol.2003 ;136:167-178.
22.
Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PLSleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med.2002;165:677-682.
23.
Vgontzas AN , Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia . J Clin Endocrinol Metab.2000;85:1151-1158.
24.
Reichmuth KJ , Austin D., Skatrud JB, Young T.Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med.2005;172:1590-1595.
25.
West SD, Nicoll DJ, Stradling JRPrevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006;61:945-950.
26.
Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S.The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med.1993;328:1230-1235.
27.
Foster G., Kuna S., Sanders M., et al. Sleep apnea in obese adults with type 2 diabetes: baseline results from the Sleep Ahead Study. Sleep.2005;28:A204.
28.
Doran SM, Van Dongen HP, Dinges DFSustained attention performance during sleep deprivation: evidence of state instability. Arch Ital Biol. 2001;139:253-267.
29.
Chugh DK, Weaver TE, Dinges DFPsychomotor vigilance performance in sleep apnea patients compared to patients presenting with snoring without apnea. Sleep. 1998;21:159.
30.
Weaver TE, Chugh DK, Maislin G., et al. Impact of obstructive sleep apnea on the conduct of daily activities . Sleep Res. 1997; 26:530.
31.
Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835-843.
32.
Dinges DF, Maislin G., Staley B., Pack F., Woodle C., Pack AISleepiness and neurobehavioral functioning in relation to apnea severity in a cohort of commercial motor vehicle operators. Sleep. 1998;21(suppl):83.
33.
Johns MWA new method for measuring daytime sleepiness: the Epworth Sleepiness Scale . Sleep. 1991;14:540-545.
34.
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res.1989;28:193-213.
35.
Maislin G., Pack AI, Kribbs NB, et al. A survey screen for prediction of apnea. Sleep . 1995;18:158-166.
36.
Punjabi NM, Beamer BASleep apnea and metabolic dysfunction. In: Kryger M, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine4th ed. Philadelphia, Pa: ElsevierSaunders;2005:1034-1042.
37.
Hein MS, Schlenker EH, Patel KPAltered control of ventilation in streptozotocin-induced diabetic rats. Proc Soc Exp Biol Med.1994;207:213-219.
38.
Polotsky VY, Wilson JA, Haines AS, et al. The impact of insulin-dependent diabetes on ventilatory control in the mouse. Am J Respir Crit Care Med.2001 ;163:624-632.
39.
Ficker JH, Dertinger SH, Siegfried W., et al. Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J. 1998 ;11:14-19.
40.
Spiegel K., Leproult R., Van Cauter E.Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-1439.
41.
Fletcher ECSympathetic activity and blood pressure in the sleep apnea syndrome. Respiration.1997;64:22-28.
42.
Cheng N., Cai W., Jiang M., Wu S.Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res.1997;41:852-856.
43.
Raff H., Bruder ED, Jankowski BM, Colman RJEffect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat. Horm Metab Res.2001;33:151-155.
Narkiewicz K., van de Borne PJ, Cooley RL, Dyken ME, Somers VKSympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98:772-776.
46.
Watanabe T. , Mano T., Iwase S., et al. Enhanced muscle sympathetic nerve activity during sleep apnea in the elderly. J Auton Nerv Syst . 1992;37:223-226.
47.
Coy TV, Dimsdale JE, Ancoli-Israel S., Clausen J.Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res.1996;5:42-50.
48.
Dimsdale JE , Coy T., Ancoli-Israel S., Mills P., Clausen J., Ziegler MGSympathetic nervous system alterations in sleep apnea: the relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest. 1997;111:639-642.
49.
Dimsdale JE , Coy T., Ziegler MG, Ancoli-Israel S., Clausen J.The effect of sleep apnea on plasma and urinary catecholamines. Sleep. 1995;18:377-381.
50.
Vgontzas AN , Papanicolaou DA, Bixler EO, Kales A., Tyson K., Chrousos GPElevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab.1997;82:1313-1316.
51.
Chin-Chance C., Polonsky KS, Schoeller DATwenty-four-hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake. J Clin Endocrinol Metab.2000;85:2685-2691.
52.
Ip MS, Lam KS, Ho C., Tsang KW, Lam W.Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000;118:580-586.
53.
Sanner BM, Kollhosser P., Buechner N., Zidek W., Tepel M.Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J. 2004;23:601-604.
54.
Strohl KP, Boehm KD, Denko CW, Novak RD, Decker MJBiochemical morbidity in sleep apnea. Ear Nose Throat J.1993; 72:34, 39-41.
55.
Bloom SR, Edwards AV, Hardy RNAdrenal and pancreatic endocrine responses to hypoxia and hypercapnia in the calf. J Physiol.1977;269:131-154.
56.
Bloom SR, Edwards AV, Hardy RN, Malinowska KWAdrenal responses to hypoxia and hypercapnia in the young calf. Experientia. 1977;33:362-363.
57.
Harsch IA, Schahin SP, Radespiel-Troger M., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med.2004;169:156-162.
Brooks B., Cistulli PA, Borkman M., et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab.1994 ;79:1681-1685.
60.
Cooper BG, White JE, Ashworth LA, Alberti KG, Gibson GJHormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep. 1995;18:172-179.
61.
Davies JJ, Turner R., Crosby J., Stradling JRPlasma insulin and lipid levels in untreated obstructive sleep apnoea: their comparison with matched controls and response to treatment. J Sleep Res. 1994;3:180-185.
62.
Saarelainen S., Lehtela J., Kallonen E.Effect of nasal CPAP treatment on insulin sensitivity and plasma leptin. J Sleep Res. 1997;6: 146-147.
63.
Stoohs RA, Facchini FS, Philip P., Valencia-Flores M., Guilleminault C.Selected cardiovascular risk factors in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure (n-CPAP). Sleep. 1993;16:S141-S142.
64.
Lojander J. , Kajaste S., Maasilta P., Partinen M.Cognitive function and treatment of obstructive sleep apnea syndrome. J Sleep Res.1999;8:71-76.
65.
Engleman HM , Kingshott RN, Martin SE, Douglas NJCognitive function in the sleep apnea/hypopnea syndrome (SAHS). Sleep.2000;23(suppl 4): S 102-S108.
66.
Engleman HM , Douglas NJCognitive effects and daytime sleepiness. Sleep.1993;16:S79.
67.
Ferini-Strambi L., Baietto C., Di Gioia MR, et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res Bull.2003;61:87-92.
68.
Dinges DF, Pack F., Williams K., et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep. 1997;20:267-277.
69.
Weaver TE, Maislin G., Dinges DF, et al. Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep. 2003;26:727-732.
70.
Yu BH, Ancoli-Israel S., Dimsdale JEEffect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res.1999;33:427-432.
71.
Bardwell WA , Berry CC, Ancoli-Israel S., Dimsdale JEPsychological correlates of sleep apnea. J Psychosom Res.1999; 47:583-596.
72.
Chasens ER, Olshansky E.The experience of being sleepy while managing type 2 diabetes. J Am Psychiatr Nurs Assoc. 2006;12: 272-278.